Detalhe da pesquisa
1.
Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol.
Future Oncol
; 20(12): 727-738, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488039
2.
Does race predict the development of metastases in men who receive androgen-deprivation therapy for a biochemical recurrence after radical prostatectomy?
Cancer
; 125(3): 434-441, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427535
3.
Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Cancer
; 124(10): 2104-2114, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29505670
4.
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.
Future Oncol
; 14(6): 527-536, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29417827
5.
Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.
BMC Urol
; 18(1): 77, 2018 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30189902
6.
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.
BMC Urol
; 18(1): 84, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30285696
7.
Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research.
Future Oncol
; 12(23): 2689-2699, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27528114
8.
Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents.
Adv Ther
; 39(6): 2515-2532, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352309
9.
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry.
Prostate Cancer Prostatic Dis
; 25(2): 314-319, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145218
10.
A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer.
Adv Ther
; 37(12): 4910-4929, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029725
11.
Treatment patterns in patients with acute myeloid leukemia in the United States: a cross-sectional, real-world survey.
Curr Med Res Opin
; 35(5): 927-935, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30712406
12.
Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis.
Adv Ther
; 35(10): 1639-1655, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30191463
13.
Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.
Adv Ther
; 35(9): 1438-1451, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29946798
14.
Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.
Adv Ther
; 35(9): 1452, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30117060
15.
Observed clinical and health services outcomes in pediatric inpatients treated with atypical antipsychotics: 1999-2003.
J Child Adolesc Psychopharmacol
; 17(3): 312-27, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17630865
16.
The economic burden of pervasive developmental disorders in a privately insured population.
Manag Care Interface
; 19(8): 39-45, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16933527
17.
Direct health care costs for children with pervasive developmental disorders: 1996-2002.
Adm Policy Ment Health
; 34(3): 213-20, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17082979